Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,503,474
+$4,337,811 QoQ
Shares Held
472,511
+101.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#144
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $144,607,995 across 17 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
6,652,349 | $62,066,416 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
567,585 | $19,229,779 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
60,224 | $10,150,152 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
17,340 | $9,395,332 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
184,209 | $8,707,559 | |
| 6 | VTRS |
Viatris Inc
This page
|
472,511 | $7,503,474 | |
| 7 | ZTS |
Zoetis Inc.
|
96,209 | $6,913,578 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
268,328 | $4,301,297 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,503,474 | 472,511 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,165,663 | 234,320 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,284,923 | 183,528 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,385,642 | 139,964 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $1,326,514 | 148,546 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,780,196 | 319,196 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $4,176,799 | 335,486 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $3,264,023 | 281,139 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $2,936,653 | 276,261 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $3,705,984 | 310,384 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $2,910,822 | 268,774 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $3,095,093 | 313,904 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $2,819,588 | 282,524 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $2,287,866 | 237,824 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $2,574,613 | 231,322 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $626,407 | 73,522 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,263,665 | 120,694 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $1,106,343 | 101,686 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $1,501,910 | 111,006 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $1,355,744 | 100,055 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,558,266 | 109,046 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $1,243,454 | 89,009 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $3,818,704 | 203,773 | Shares | Other | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||